DK0650480T3 - 1-Arylsulfonyl-3-phenyl-1,4,5,6-tetrahydropyridaziner - Google Patents

1-Arylsulfonyl-3-phenyl-1,4,5,6-tetrahydropyridaziner

Info

Publication number
DK0650480T3
DK0650480T3 DK93917006T DK93917006T DK0650480T3 DK 0650480 T3 DK0650480 T3 DK 0650480T3 DK 93917006 T DK93917006 T DK 93917006T DK 93917006 T DK93917006 T DK 93917006T DK 0650480 T3 DK0650480 T3 DK 0650480T3
Authority
DK
Denmark
Prior art keywords
pct
group
chch
radical
proviso
Prior art date
Application number
DK93917006T
Other languages
English (en)
Inventor
Donald W Combs
Original Assignee
Ortho Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Pharma Corp filed Critical Ortho Pharma Corp
Application granted granted Critical
Publication of DK0650480T3 publication Critical patent/DK0650480T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/04Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509Six-membered rings
    • C07F9/650905Six-membered rings having the nitrogen atoms in the positions 1 and 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Medicinal Preparation (AREA)
DK93917006T 1992-07-01 1993-07-01 1-Arylsulfonyl-3-phenyl-1,4,5,6-tetrahydropyridaziner DK0650480T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US90698492A 1992-07-01 1992-07-01
US8098693A 1993-06-21 1993-06-21
PCT/US1993/006394 WO1994001412A1 (en) 1992-07-01 1993-07-01 1-arylsulphonyl, arylcarbonyl and 1-arylphosphonyl-3-phenyl-1,4,5,6-tetrahydropyridazines

Publications (1)

Publication Number Publication Date
DK0650480T3 true DK0650480T3 (da) 2002-05-13

Family

ID=26764215

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93917006T DK0650480T3 (da) 1992-07-01 1993-07-01 1-Arylsulfonyl-3-phenyl-1,4,5,6-tetrahydropyridaziner

Country Status (14)

Country Link
US (1) US5684151A (da)
EP (1) EP0650480B1 (da)
JP (1) JPH07508987A (da)
AT (1) ATE209189T1 (da)
AU (1) AU668206B2 (da)
BR (1) BR9306661A (da)
CA (1) CA2139307A1 (da)
DE (1) DE69331196T2 (da)
DK (1) DK0650480T3 (da)
ES (1) ES2168276T3 (da)
HU (1) HUT68424A (da)
NZ (1) NZ254534A (da)
PT (1) PT650480E (da)
WO (1) WO1994001412A1 (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4430755A1 (de) * 1994-08-30 1996-03-07 Boehringer Mannheim Gmbh Neue Phosphanoxide, Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende Arzneimittel
US5707985A (en) * 1995-06-07 1998-01-13 Tanabe Seiyaku Co. Ltd. Naphthyl-, quinolyl- and isoquinolyl- sulfonamide derivatives as cell adhesion modulators
DE19632549A1 (de) * 1996-08-13 1998-02-19 Merck Patent Gmbh Arylalkanoylpyridazine
DE19723722A1 (de) * 1997-05-30 1998-12-10 Schering Ag Nichtsteroidale Gestagene
US6107295A (en) * 1997-08-01 2000-08-22 Merck Patent Gesellschaft Mit Beschrankter Haftung Arylalkanoyl pyridazines
DE19850701A1 (de) 1998-11-04 2000-05-11 Merck Patent Gmbh Benzoylpyridazine
US6417189B1 (en) 1999-11-12 2002-07-09 Gpi Nil Holdings, Inc. AZA compounds, pharmaceutical compositions and methods of use
US7253169B2 (en) 1999-11-12 2007-08-07 Gliamed, Inc. Aza compounds, pharmaceutical compositions and methods of use
DE10064997A1 (de) * 2000-12-23 2002-06-27 Merck Patent Gmbh Benzoylpyridazine
US7402704B2 (en) * 2004-04-14 2008-07-22 Amgen Inc. Arylsulfones and uses related thereto
AU2007327707B2 (en) 2006-10-24 2012-07-12 Allergan pharmaceuticals International Ltd. Compositions and methods for suppressing endometrial proliferation
BRPI0819571A2 (pt) * 2007-12-20 2019-09-24 Teva Womenss Health Inc "método para contracepção de emergência, pacote farmacêutico para contracepção de emergência e composição farmacêutica"
TWI539953B (zh) 2008-04-28 2016-07-01 瑞波若斯治療學公司 用於治療乳癌之組成物和方法
CN107260745A (zh) 2010-03-22 2017-10-20 利普生物药剂公司 用于抗孕酮的非毒性递送的组合物和方法
JOP20200024A1 (ar) 2017-08-04 2020-02-02 Bayer Ag مركبات ثنائي هيدروكساديازينون
CA3071795A1 (en) * 2017-08-04 2019-02-07 Bayer Aktiengesellschaft 6-phenyl-4,5-dihydropyridazin-3(2h)-one derivatives as pde3a and pde3b inhibitors for treating cancer
TWI750573B (zh) 2019-02-01 2021-12-21 德商拜耳廠股份有限公司 1,2,4-三-3(2h)-酮化合物

Also Published As

Publication number Publication date
ES2168276T3 (es) 2002-06-16
AU668206B2 (en) 1996-04-26
EP0650480A1 (en) 1995-05-03
PT650480E (pt) 2002-03-28
EP0650480B1 (en) 2001-11-21
DE69331196T2 (de) 2002-07-25
US5684151A (en) 1997-11-04
JPH07508987A (ja) 1995-10-05
BR9306661A (pt) 1998-12-08
CA2139307A1 (en) 1994-01-20
DE69331196D1 (de) 2002-01-03
WO1994001412A1 (en) 1994-01-20
NZ254534A (en) 1997-12-19
HUT68424A (en) 1995-06-28
ATE209189T1 (de) 2001-12-15
HU9403841D0 (en) 1995-02-28
AU4667093A (en) 1994-01-31

Similar Documents

Publication Publication Date Title
DE69331196D1 (de) 1-arylsulfonyl-3-phenyl-1,4,5,6-tetrahydropyridazinen
ATE168101T1 (de) Arylpyridazinone
ATE37179T1 (de) Dihydropyridazinone.
ES8604854A1 (es) Un procedimiento para la preparacion de un compuesto coulante para el tenido del cabello por oxidacion.
CA2159817A1 (en) Pyrimidine Acyclonucleoside Derivatives
ES2000779A6 (es) Un procedimiento para preparar derivados de piridazinona y metodo para reprimir plagas de insectos usando dichos derivados.
AU560607B2 (en) Pyridazinones their preparation and use and medicaments containing pyridazinones
ATE163402T1 (de) Substituierte ortho- ethenylphenylessigsäurederivate
ATE191465T1 (de) Carbamoylcarbonsäureamide
TW198680B (da)
TW334340B (en) Preparation for pyrazolyl derivatives
ES8402824A1 (es) Procedimiento para la preparacion de un derivado de acido imidazolcarboxilico.
DE3467297D1 (en) Benzobicyclononane amino derivatives with anticonvulsive properties
ES8307798A1 (es) Un procedimiento para la preparacion de derivados de piperazilmetil-4-dibenzofuranona, o, dibenzofuranol.
TW289019B (da)
KR900000330A (ko) 벤젠 유도체